S. Vincendeau

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 330 citations

Medicine, Oncology, Pharmacology +15

Haralick textural features on<i>T</i>₂-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer

K. Gnep, Auréline Fargeas, Ricardo Enrique Gutiérrez Carvajal et al. · Journal of Magnetic Resonance Imaging · 2016 · 158 citations · Full text

Medicine, Oncology, Radiology +17

Multicenter Evaluation of [−2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer

Carsten Stephan, S. Vincendeau, A. Houlgatte et al. · Clinical Chemistry · 2012 · 138 citations · Full text

Medicine, Oncology, Urology +17

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings

Peter Ka‐Fung Chiu, Chi‐Fai Ng, Axel Semjonow et al. · European Urology · 2018 · 97 citations

Medicine, Oncology, Urology +15

Pathologic Findings in Radical Prostatectomy Specimens From Patients Eligible for Active Surveillance With Highly Selective Criteria: A Multicenter Study

Jean‐Baptiste Beauval, Guillaume Ploussard, M. Soulié et al. · Urology · 2012 · 67 citations

Medicine, Surgery, Urology +16